Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Core EBITDA Growth

    Back to All Ratios
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 30.5618.712.3331.472.78

What is the latest Core EBITDA Growth ratio of WINDLAS BIOTECH ?

The latest Core EBITDA Growth ratio of WINDLAS BIOTECH is 30.56 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202430.56
Mar202318.71
Mar20222.33
Mar202131.47
Mar20202.78

How is Core EBITDA Growth of WINDLAS BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2024 30.56
63.34
Mar2023 18.71
703.00
Mar2022 2.33
-92.60
Mar2021 31.47
1,032.01
Mar2020 2.78 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Core EBITDA Growth ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,211.6 Cr -7.4% 3.4% 156.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,948.0 Cr -0% 0.5% 46.9% Stock Analytics
DIVIS LABORATORIES ₹157,873.0 Cr -3% 0.9% 61.2% Stock Analytics
CIPLA ₹116,809.0 Cr -2.1% -6.9% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,963.0 Cr -0.6% -3.3% 7.4% Stock Analytics
ZYDUS LIFESCIENCES ₹98,173.2 Cr -1.9% 0.7% 54.5% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-7.4%

3.4%

156.1%

SENSEX

-0.6%

2.3%

16.9%


You may also like the below Video Courses